Coinbase Shakes Up the Market: BIO and EUL Tokens Surge 17% and 3.5% on Roadmap Addition
Coinbase has once again sent shockwaves through the crypto market by adding Bio Protocol (BIO) and Euler (EUL) to its asset roadmap. This move triggered immediate price surges, with BIO jumping 17% and EUL gaining 3.5%. But what does this mean for investors and the broader DeFi and DeSci ecosystems?
What is the Coinbase Effect on BIO and EUL Tokens?
The so-called “Coinbase effect” has historically caused short-term price volatility for tokens added to the exchange’s roadmap. While BIO saw a dramatic 17% surge before retreating slightly, EUL’s 3.5% gain was more modest. This difference highlights how established tokens (both already trade on Binance and Kraken) may see less dramatic moves than newer assets.
BIO Token: Powering the DeSci Revolution
BIO serves as the native token for BioDAOs, a decentralized science (DeSci) platform that enables:
- Community-governed biotech research
- Intellectual property tokenization
- Decentralized funding for scientific projects
EUL Token: A DeFi Lending Powerhouse
Euler Finance’s governance token (EUL) facilitates:
- Permissionless lending and borrowing on Ethereum
- Support for niche crypto assets
- Decentralized financial infrastructure
Should Investors Expect Long-Term Gains?
While the initial price movements are exciting, analysts caution that:
- Both tokens already have significant liquidity on other exchanges
- The DeFi and DeSci sectors face intense competition
- Historical precedent shows many tokens give back initial gains
FAQs About the Coinbase BIO and EUL Listing
Q: Does Coinbase’s roadmap guarantee a listing?
A: No, inclusion only indicates the tokens are under evaluation.
Q: Why did BIO surge more than EUL?
A: BIO’s smaller market cap and DeSci niche may have attracted more speculative interest.
Q: Where can I trade these tokens now?
A: Both are available on Binance, Kraken, OKX, and MEXC.
Q: What risks should investors consider?
A: Market saturation, competition, and potential “sell the news” events post-listing.
